Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021)
Minerva Neurosciences posted quarterly Other Non-Current Assets of $14808.0 for Q2 2021, little changed year-on-year from $14808.0 in Q2 2020, and little changed on a QoQ basis from $14808.0 in Q1 2021.
Minerva Neurosciences (NERV) has 7 years of Other Non-Current Assets data on file, last reported at $14808.0 in Q2 2021.
- For the quarter ending Q2 2021, Other Non-Current Assets changed 0.0% year-over-year to $14808.0; the trailing twelve-month figure through Jun 2021 stood at $14808.0 (changed 0.0% YoY), and the FY2020 full-year result was $14808.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q2 2021 stood at $14808.0, roughly flat from $14808.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $14808.0 in Q4 2017 and bottomed at $14808.0 in Q4 2017.
- The 5-year median for Other Non-Current Assets is $14808.0 (2017), against an average of $14808.0.
- Peak annual rise in Other Non-Current Assets reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
- A 5-year view of Other Non-Current Assets shows it stood at $14808.0 in 2017, then changed by 0.0% to $14808.0 in 2018, then changed by 0.0% to $14808.0 in 2019, then changed by 0.0% to $14808.0 in 2020, then changed by 0.0% to $14808.0 in 2021.
- The last three Other Non-Current Assets figures came in at $14808.0 (Q2 2021), $14808.0 (Q1 2021), and $14808.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 14,808.00 |
| Mar 31, 2021 | 14,808.00 |
| Dec 31, 2020 | 14,808.00 |
| Sep 30, 2020 | 14,808.00 |
| Jun 30, 2020 | 14,808.00 |
| Mar 31, 2020 | 14,808.00 |
| Dec 31, 2019 | 14,808.00 |
| Sep 30, 2019 | 14,808.00 |
| Jun 30, 2019 | 14,808.00 |
| Mar 31, 2019 | 14,808.00 |
| Dec 31, 2018 | 14,808.00 |
| Sep 30, 2018 | 14,808.00 |
| Jun 30, 2018 | 14,808.00 |
| Mar 31, 2018 | 14,808.00 |
| Dec 31, 2017 | 14,808.00 |
| Jun 30, 2014 | 3.11 Mn |
| Dec 31, 2013 | 433,998.00 |